Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma
Authors:
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 46 (2) , 311-325
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinomaLaboratory Investigation, 2013
- Hepatocellular CarcinomaSurgical Pathology Clinics, 2013
- Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration SpecimensAmerican Journal of Clinical Pathology, 2012
- Fibrolamellar carcinomas are positive for CD68Laboratory Investigation, 2010
- Arginase-1American Journal of Surgical Pathology, 2010
- Hepatocellular adenomasLiver International, 2008
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursNature, 2008
- The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell originHistopathology, 2006
- Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCCHepatology, 2006
- The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaLaboratory Investigation, 2005